🇺🇸 FDA
Patent

US 8252839

Compounds and methods for delivery of prostacyclin analogs

granted A61KA61K31/192A61K31/216

Quick answer

US patent 8252839 (Compounds and methods for delivery of prostacyclin analogs) held by United Therapeutics Corporation expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/192, A61K31/216, A61K31/223, A61K31/235